Trial · NCT02168478
Neo-Synalar Modified 48 Hour Patch Test
NCT02168478, Phase 4, Completed, Noah Rosenberg, MD; results first posted 2015-12-11
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Neo-Synalar Modified 48 Hour Patch Test. Trials, record NCT02168478. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02168478
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Neo-Synalar Modified 48 Hour Patch Test
- NCT number
- NCT02168478
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 206 participants, actual
- Lead sponsor
- Noah Rosenberg, MD
- Conditions
- Allergy
- Interventions
- Neo-Synalar Cream, Sodium Lauryl Sulfate Aqueous Solution (0.40%), Saline
- First posted
- 2014-06-20
- Last updated
- 2015-12-11
- Results first posted
- 2015-12-11
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Evidence of Pre-Existing Sensitization by Use of the Erythemal Scoring Scale (ESS) | 48, 96 and 168 Hours | ESS is measured at 48, 96 and 168 hours post-application of study material. The Erythemal Scoring Scale (ESS) is defined as a 6 point scale (0-4). "0"= no visible erythema; "0.5"= slight, barely perceptible erythema; "1"= mild erythema; "2"= moderate erythema; "3"= marked erythema; "4"= severe erythema. An ESS score of 1 or greater that persists or worsens from one visit to the next is defined as pre-existing sensitization. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Evidence of Pre-Existing Sensitization by Use of the Erythemal Scoring Scale (ESS) | 48, 96 and 168 Hours | percentage of patients w allergic rxn | NUMBER |
Source ClinicalTrials.gov
Results by group1
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Evidence of Pre-Existing Sensitization by Use of the Erythemal Scoring Scale (ESS) | Patch Test Group | 0 | percentage of patients w allergic rxn |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Patch Test Group | 206 | |
| Overall Study | COMPLETED | Patch Test Group | 202 | |
| Overall Study | NOT COMPLETED | Patch Test Group | 4 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Patch Test Group | ||
| Total, other adverse events | Patch Test Group | 0 | 202 |
| Total, serious adverse events | Patch Test Group | 0 | 202 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02168478
GET https://conductscience.org/api/trials/v1/NCT02168478/registered